FGF1 and idiopathic pulmonary fibrosis: Similarly, FGF-1 levels are also increased in IPF lung tissue, where it inhibits transforming growth factor-beta 1 (TGF-β1)-stimulated myofibroblast differentiation and epithelial-mesenchymal transition (EMT), thereby functioning as an antifibrotic agent (36).